Adapting LFI for Melioidosis

Status Completed

Clinical Trial Summary

Towards the goal of reducing melioidosis, this study will help clinicians in Sarawak to diagnose and understand the causes and risk factors for melioidosis. The data will help the clinicians to provide faster test results and better clinical care. The investigator's laboratory efforts will supplement available diagnostics by adding a new, easier-to-use test involving lateral flow immunoassay to rapidly detect Burkholderia pseudomallei, a bacterium causing melioidosis. The study aims to study up to 400 patients with melioidosis-like symptoms who are admitted to Kapit Hospital, Sarawak, Malaysia. No participants will be enrolled from other sites. The study will also examine the demographic, behavioral and occupational risk factors associated with hospital admissions to understand any existing associations between these variables and melioidosis prevalence.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Melioidosis

Clinical Trial Details

NCT number	NCT03528265
Study type	Observational
Source	Duke University
Contact
Status	Completed
Phase
Start date	June 21, 2018
Completion date	January 8, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04299412` - Diagnostic Accuracy of the DPP II Assay
Recruiting	`NCT06089668` - An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis
Completed	`NCT05105035` - Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients	Phase 2
Completed	`NCT01766830` - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)	N/A
Recruiting	`NCT03048513` - Clinical Presentation of Melioidosis in Head and Neck Region	N/A
Completed	`NCT02668406` - Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis
Recruiting	`NCT00579956` - A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis	N/A
Completed	`NCT01420341` - Co-trimoxazole as Maintenance Therapy for Melioidosis	Phase 4
Completed	`NCT02089152` - A Single-blind Stepped Wedge Cluster Randomized Controlled Behaviour Change Trial to Determine Effectiveness of Prevention Programme of Melioidosis in Diabetics in Ubon Ratchathani, Northeast Thailand	N/A